780 



GE1S T EKAL INDEX 



Intoxications, pathological changes in 

 suprarenals as result of, ii, 261. 



ocular symptoms due to, ii, 781. 



tetany associated with, i, 650. 



prognosis of, i, 670. 



Intoxication theory of parathyroid 



tetany, toxic agent, ammonia as, i, 

 542. 



guanidin and methylguanidin as, 



i, 544. 



histamin as, i, 544. 



inosinic acid, i, 549. 



thymus secretion, i, 549. 



xanthin as, i, 544. 



Intra-ocular tension, in relation to nu- 

 trition and secretion, ii, 768. 



Intra-ocular tissue, neuro - endocrin 

 control of, ii, 769. 



Intrapulmonary injections of gland 

 extracts, i, 35. 



Intrathoracic struma, i, 318. 



Intravenous coagulation, due to sub- 

 stances in unboiled tissue extracts, i, 

 30. 



Intravenous feeding, iii, 817. 



of carbohydrates, iii, 817. 



dangers of, iii, 817. 



indications for, iii, 817. 



of fats, iii, 817. 



of proteins, iii, 817. 

 Intravenous injection of fluids. See 



Fluids. 



Intravenous injections, errors and ad- 

 vantages of, i, 32. 



given apparently specific reaction 

 obtained from extracts of several 

 different glands, i, 30. 



gland extract as heterogeneous mix- 

 ture of many substances, i, 29; 



immunity developed, i, 31. 



intravenous coagulation induced by 

 substances in unboiled tissue ex- 

 tracts, i, 30. 



nonspecific substances in tissue ex- 

 tract, cholin, i, 29. 



histamin, i, 29. 



nucleo-proteins, i, 29. 



of suprarenal extracts, Oliver and 

 Sehaefer's experiment on effects of, 

 i, 28. 



postulates to prove hormone con- 

 tent in given organ extract, i, 

 28. 



quantitative aspects of, i, 31. 



sources of error in experiments on, 

 Biedl on, i, 28. 



Gley on, i, 28. 



Lewandowsky on, i, 28, 



Intravenous injections, toxic material 

 due to process of disintegration of 

 protein substances, i, 29. 



anaphylactic shock as factor in, 



i, 29. 



boiling as means of eliminating, 



i, 30. 



tryptic enzymes of blood in for- 

 mation of, i, 29. 



variation in abnormal products of 

 extract, even in same gland, i, 32. 



Inulin, iii, 247. 



"lod-Basedow" complex of Kocher, i, 



301. 

 lodid, experimental feeding with, i, 



233-235. 

 lodids, effect of, on metabolism, iii, 



724. 

 lodin administration, atrophy of the 



thyroid gland following, i, 283. 



compounds, iii, 333. 



of, in other tissues than thyroid, 

 i, 252. 



internal secretion, evidence 

 connecting, i, 259. 



in thyroid gland, iodothyroglobu- 



lin, i, 253, 261. 



"thyreoantitoxin," S. Frankl's, 



i, 253. 



-"thyroidin" (iodothyrin), Bau- 

 mann's, i, 253, 260. 



"thyroprotein," Notkin's, i, 



253. 



-thyroxin, i, 254, 261. 



content of, in thyroid gland, i, 84, 

 248. 



age, i, 250. 

 diet, i, 251. 



distribution of, i, 252. 



of man and animals, iii, 332. 



relationship between thyroid 



activity and, i, 262. 



seasonal variations, i, 250. 



sex, i, 250. 



table of, i, 249. 



therapeutic efficiency of thy- 

 roid preparations running parallel to, 

 i, 85. 



distribution of, in organisms, i, 247. 



effect of, on metabolism, iii, 724. 



Hunter's and Kendall's method for 

 detecting presence of, i, 246. 



in parathyroids, i, 551. 



lack of, in food and drinking water, 

 iii, 333. 



metabolism, relation of thyroid 

 gland to, suggested by discovery of 

 iodothyrin in body, i ? 63. 



